ChemicalBook > Product Catalog >API >Nervous system drugs >Antidepressants, Antimanics drugs >Reboxetine

Reboxetine

Reboxetine Structure
CAS No.
98769-81-4
Chemical Name:
Reboxetine
Synonyms
REBOXETINE;Reboxetine USP/EP/BP;Reboxetine Impurity 1;(2R)-2-[(R)-(2-Ethoxyphenoxy)phenylmethyl]morpholine
CBNumber:
CB6726230
Molecular Formula:
C19H23NO3
Molecular Weight:
313.39
MOL File:
98769-81-4.mol
MSDS File:
SDS
Modify Date:
2026/5/20 15:44:59

Reboxetine Properties

Melting point 170-171°

SAFETY

Risk and Safety Statements

Hazardous Substances Data 98769-81-4(Hazardous Substances Data)

Reboxetine price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Product number Packaging Price Buy

Reboxetine Chemical Properties,Uses,Production

General Description

Most of the activity of reboxetine resides in the S,S-isomer(The marketed compound is RR and SS.) It is claimed to besuperior to fluoxetine in severe depression. It is marketed inEurope. At least three tricyclic compounds, desipramine,nortriptyline, and the technically tetracyclic maprotiline areSNERIs. They, of course, have typical characteristic TCAside effects but lower anticholinergic and H1-antihistaminic(sedative) effects than dimethyl compounds. SNERIs areclinically effective antidepressants.
It would be expected that in the case of SNERIs,α2presynaptic receptors would be desensitized, after whichsustained NE transmission would be via one or more postsynapticreceptors; α1, β1, and β2 receptors are possibilities.

Clinical Use

Reboxetine is a nontricyclic SNRI in which the propylamine side chain of the TCAs is constrained into a morpholine ring. It is a potent and selective ligand for the NET, with a mechanism of action is similar to that of desipramine. Reboxetine is used for the treatment of major depressive disorders. It is a chiral compound that is marketed as a racemic mixture of R,R- and S,S-reboxetine. The antidepressant activity for reboxetine appears to reside with the S,S-(+)-enantiomer, which has approximately twofold the inhibition potency of the R,R-enantiomer. It is well tolerated, with different adverse-event profiles, and it appears to be at least as effective as the SSRIs in the treatment of depressive illness. Currently, it is available only in Europe and is under U.S. FDA review. It preferentially inhibits the reuptake of NE (5-HT :NE ratio, 8). Reboxetine is not metabolized by the polymorphic isoforms, CYP2D6 or CYP2C19, and may offer a valuable alternative to the secondary amine TCAs in the treatment of major depression. Reboxetine is likely to become a promising alternative for patients who have failed treatment with or do not tolerate serotonergic antidepressants.

Side effects

Reboxetine is relatively well tolerated, with insomnia, sweating, constipation, and dry mouth being commonly reported adverse events. Hypotension and urinary hesitancy occur at lower rates than with the TCAs. When compared with the SSRIs, reboxetine is associated with lower rates of nausea, somnolence, and diarrhea.

Drug interactions

Reboxetine seems to be an antidepressant that has negligible interference with the pharmacokinetics of other drugs; thus, fewer drug–drug interactions are expected. It also may be possible to use reboxetine in combination with MAOIs, because it has no inhibitory effect on this enzyme, which would avoid tyramineinduced hypertensive reactions.

Reboxetine Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 38)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6486 58 Inquiry
CONIER CHEM AND PHARMA LIMITED China 49897 58 Inquiry
Career Henan Chemica Co +86-0371-86658258 +86-13203830695 China 30202 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 29086 58 Inquiry
Dayang Chem (Hangzhou) Co.,Ltd. +86-0571-88938639 17705817739 China 52445 58 Inquiry
Zibo Hangyu Biotechnology Development Co., Ltd +86-0533-2185556 +86-15965530500 China 9900 58 Inquiry
HANGZHOU LEAP CHEM CO., LTD. +86-571-87711850 +86-15355479329 China 43303 58 Inquiry
Amadis Chemical Company Limited 571-89925085 China 131885 58 Inquiry
Shanghai Yanjin Biological Technology Co., Ltd. 021-65232515 CHINA 6886 58 Inquiry
Wuhan Yanzhe Technology Co., Ltd 15527250409 China 4152 58 Inquiry
REBOXETINE (2R)-2-[(R)-(2-Ethoxyphenoxy)phenylmethyl]morpholine Reboxetine Impurity 1 Reboxetine USP/EP/BP 98769-81-4 71260-89-8 Inhibitor